Major Depressive Disorder (MDD) Treatment Market, 2016-2026 by Segmentation: Based on Product, Application and Region
Share, Global Trends,
Analysis, Research, Report,
Segmentation and Forecast,
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
For detailed subscription information please contact
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Major Depressive Disorder (MDD) is one of the most common mental disorder
characterized by persistent and tenacious low mood that interferes with the person’s
ability to work, eat, sleep and normal activities. MDD is also referred as clinical
depression, major depression, and unipolar depression or as recurrent depression. The
common symptoms associated with this disorder include insomnia, loss of interest,
recurrent thoughts of death, feelings of worthlessness and reduced ability to think.
Increasing number of patients suffering from MDD has grabbed the attention of MDD
drugs manufacturer to invest into MDD treatment market.
Major Depressive Disorder (MDD) Treatment Market: Drivers and Restraints
Work life imbalances due to change in life style, and increase in MDD patient pool are the
key drivers expected to drive the MDD treatment market over the forecasted period.
Partnerships for co-development and co-marketing of MDD drugs among the drug
manufactures across the globe, development of new drugs, and adequate government
reimbursement policies have also fueled the growth of MDD treatment market. However,
stringent regulations imposed by various governments for new drug approval, patent
expiries of some blockbuster drugs, risk of complications with other edications, elated
side effects of MDD drugs may hinder the growth of MDD treatment market over the
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1314
Major Depressive Disorder (MDD) Treatment Market: Segmentation
The global MDD treatment market is segmented based on drug type used for the
treatment of MDD.
• Selective Serotonin Reuptake Inhibitors (Ssris)
• Dopamine Norepinephrine Reuptake Inhibitor
• Serotonin Norepinephrine Reuptake Inhibitor
• Serotonin Modulators
• Norepinephrine-Serotonin Modulator
• Tricyclics and Tetracyclics
• Monoamine Oxidase Inhibitors (MAOIs)
• Irreversible, non-selective inhibitors
• Irreversible, MAO B selective inhibitor
• Selegiline transdermal
• Reversible, MAO A selective inhibitor
Major Depressive Disorder (MDD) Treatment Market: Overview
At present, antidepressants are most commonly used drugs for the treatment of MDD,
and has the largest market segment. Major brands of SSRI’s include Citalopram,
Escitalopram, Fluoxetine, Paroxetine, and Sertraline. Bupropion, Mirtazapine, and
Razodone, are atypical antidepressants frequently used for the treatment of MDD. Major
brands of antipsychotics includes Resperidone, Olanzapine, Quetiapine, Ziprasidone, and
Aripiprazole. Global MDD treatment market is expected to grow with a healthy CAGR
owing to increase in MDD patient pool over the forecast period.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1314
Major Depressive Disorder (MDD) Treatment Market: Region-wise Outlook
Geographically, North America market is estimated to hold maximum market revenue
share in global MDD treatment market owing to increase in number of patients suffering
from MDD, and advancement in technology to develop new therapeutic drugs and
followed by Europe and Asia-Pacific respectivily. The market in Asia-Pacific is expected to
expand at a significant CAGR over the forecasted period due to increasing awareness for
depression conditions and complications associated with it.
MDD treatment market is expected to register healthier CAGR in emerging markets such
as India, China, and Brazil compared to other developed regions in the world.
Major Depressive Disorder (MDD) Treatment Market: Key Players
Key companies operational in MDD treatment market are Eli Lilly and Company, Johnson
& Johnson, Pfizer, Inc., AstraZeneca plc, Merck & Co., GlaxoSmithKline plc, Sanofi S.A.,
Shire plc, Novartis AG, Janssen Pharmaceutical, Inc., and others.
Browse full report: http://www.futuremarketinsights.com/reports/major-depressivedisorder-treatment-market
To know more about us, please visit our website:
For sales queries or new topics email us on:
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705